Pacer Advisors Inc. lowered its stake in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 93.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,285 shares of the company’s stock after selling 124,059 shares during the quarter. Pacer Advisors Inc.’s holdings in Henry Schein were worth $676,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. IFP Advisors Inc raised its position in Henry Schein by 8.7% in the fourth quarter. IFP Advisors Inc now owns 2,698 shares of the company’s stock worth $389,000 after acquiring an additional 217 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Henry Schein by 9.7% during the fourth quarter. JPMorgan Chase & Co. now owns 3,652,198 shares of the company’s stock worth $291,700,000 after buying an additional 322,602 shares in the last quarter. Geode Capital Management LLC grew its position in Henry Schein by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 3,209,794 shares of the company’s stock worth $255,960,000 after buying an additional 18,816 shares during the last quarter. BI Asset Management Fondsmaeglerselskab A S grew its position in Henry Schein by 4.3% in the fourth quarter. BI Asset Management Fondsmaeglerselskab A S now owns 7,350 shares of the company’s stock worth $587,000 after buying an additional 305 shares during the last quarter. Finally, Fox Run Management L.L.C. acquired a new stake in shares of Henry Schein during the 4th quarter valued at $539,000. Institutional investors own 94.75% of the company’s stock.
Henry Schein Stock Down 1.0 %
NASDAQ:HSIC traded down $0.83 during trading hours on Tuesday, reaching $79.40. The company’s stock had a trading volume of 231,580 shares, compared to its average volume of 853,175. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.82 and a quick ratio of 0.94. The company has a market cap of $10.40 billion, a price-to-earnings ratio of 22.82, a price-to-earnings-growth ratio of 2.26 and a beta of 0.84. Henry Schein, Inc. has a one year low of $64.75 and a one year high of $89.72. The business’s 50-day moving average is $77.48 and its 200-day moving average is $80.24.
Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its quarterly earnings data on Tuesday, May 9th. The company reported $1.21 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.02). The firm had revenue of $3.06 billion during the quarter, compared to analyst estimates of $3.09 billion. Henry Schein had a return on equity of 15.41% and a net margin of 3.82%. Henry Schein’s quarterly revenue was down 3.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.30 earnings per share. Equities research analysts predict that Henry Schein, Inc. will post 5.26 EPS for the current year.
Analysts Set New Price Targets
Several analysts have issued reports on HSIC shares. Barrington Research cut their price objective on Henry Schein from $92.00 to $90.00 in a report on Wednesday, May 10th. StockNews.com lowered Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, May 11th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $86.14.
Insiders Place Their Bets
In other news, EVP Mark E. Mlotek sold 24,747 shares of the firm’s stock in a transaction on Friday, May 19th. The shares were sold at an average price of $76.68, for a total value of $1,897,599.96. Following the sale, the executive vice president now owns 69,138 shares in the company, valued at $5,301,501.84. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other Henry Schein news, EVP Mark E. Mlotek sold 24,747 shares of the firm’s stock in a transaction on Friday, May 19th. The shares were sold at an average price of $76.68, for a total value of $1,897,599.96. Following the sale, the executive vice president now directly owns 69,138 shares in the company, valued at approximately $5,301,501.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman James P. Breslawski sold 24,234 shares of the company’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $74.29, for a total transaction of $1,800,343.86. Following the transaction, the insider now directly owns 201,555 shares of the company’s stock, valued at approximately $14,973,520.95. The disclosure for this sale can be found here. Insiders have sold a total of 75,019 shares of company stock valued at $5,651,018 in the last three months. Company insiders own 1.14% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.